Search filters

Filters
Clear All

Phase

  • 4
  • 3
  • 3
  • 6
  • 2
  • 43
  • 60
  • 38
  • 1
  • 3
  • 57

Found 61 Menstruation trials

A listing of Menstruation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

22-75 years
All genders
Phase 1
This dual-site, double-blinded, randomized, sham-controlled, crossover study is to assess the safety, feasibility, and preliminary efficacy of SEEG-guided multi-lead DBS in 10 participants suffering from severe symptoms of chronic, treatment-refractory OCD. Stage 1: Invasive SEEG Monitoring and Recovery Goal: To perform stimulation mapping studies and SEEG recordings, that aid in …
 CARDIO-TTRansform OLE
99 years and younger
All genders
This is a multicenter, open-label extension of the ION-682884-CS2 Study (CARDIO-TTRansform) and of the ISIS 420915-CS101 Study. Eligible participants will receive eplontersen once every 4 weeks for up to 36 months or 6 months after eplontersen is approved and available in the site's country, whichever occurs first. Participants will also …
 TRIUMPH-OUTCOMES
99 years and younger
All genders
Phase 3
The main purpose of this study is to learn more about retatrutide, an investigational treatment for participants with BMI of greater than or equal to 27 kg/m2 (kilogram per square meter) and heart related and/or kidney related disease. About 10,000 participants will be randomized to receive either retatrutide or placebo …
 Insights in Hypertrophic Cardiomyopathy and Observational Outcomes in Real World (DISCOVER-HCM)
18-99 years
All genders
Phase 4
The purpose of this registry is to understand the safety and effectiveness of various medications used in treating the condition of symptomatic obstructive hypertrophic cardiomyopathy (HCM), a type of heart disease that causes the muscular wall in the chambers of the heart to thicken which can cause blood flow in …
 Effect of study drug IL-4RR576 polymorphism on response to dupilumab in asthma
18-99 years
All genders
Phase 4
The purpose of this study is to learn if the study drug (Dupixent® Dupilumab) helps to control asthma. We are particularly interested in understanding if people who have a certain genetic make-up (genotype) will respond better to this treatment. Participants will take inhaler (Dulera®mometasone/formoterol) about 2-12 weeks. Total study duration …
 Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
18-99 years
All genders
The purpose of this study is to evaluate if closing off the left atrial appendage (LAA) of your heart (a small-sack like structure that is part of the upper chamber of the heart) during scheduled heart surgery with a surgical device known as the AtriClip, reduces the risk of a …
18 years and older
All genders
The purpose of this study includes the following: ·         To test the efficacy and safety of the Study Drug and to find out what effects, good and/or bad, it has on you and your cancer. ·         To understand how the body absorbs and processes the Study Drug by measuring the …
 ACCLAIM-Lp(a) EZEF
99 years and younger
All genders
Phase 3
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular (CV) risk in participants with high lipoprotein(a) who have CV disease or are at risk of a heart attack or stroke. The study aims to learn whether lepodisiran can reduce problems like heart attack or …
 Left vs Left RCT
99 years and younger
All genders
This study aims to test the comparative effectiveness of His or Left bundle branch pacing in relation to patient centered outcomes (quality of life, physical activity, heart failure hospitalization, mortality) and comparative safety in relation to device-related complications. This is for patients with heart failure who are already receiving current …
99 years and younger
All genders
This protocol is to see the affects of different combination therapy of Pozelimab and Cemdisiran in patient's with Symptomatic generalized myasthenia gravis. The study is split into 5 different parts: Screening. randomization and double blind study treatment period, double blind extension study treatment period, open-label study treatment period, and follow …